Abstract

Teixeira MA, Papini JZB, Garcez A, Tofoli GR. J Biophotonics. 2021;17:e202100213.
This study compared the effectiveness of 2 laser wavelengths for stimulating acupoints in an animal experimental model of acute postoperative pain. Forty-five Wistar rats were assigned randomly to receive the treatment on their left hind paws, contralateral to a surgical procedure in their right paws.
Laser treatments were performed with a green laser (GL; 532 nm, 70 mW, and 7 J/cm2 of energy), a red laser (660 nm, 100 mW, and 7 J/cm2 of energy), or with a laser off. After each application, the rats were evaluated with a Von Frey Anesthesiometer to check for painful sensitivity on their right (with surgery) and left (without surgery) hind paws. Neuropeptides and cytokine levels in the incision-site tissues of the right paws were measured by enzyme-linked immunosorbent assay after 1, 6, and 24 hours.
Both lasers promoted analgesia in the rats, and the GL altered their levels of tumor-necrosis factor–α and interleukin-1β.
Han QQ, Fu Y, Le JM, et al.. J Cancer. 2021;12(23):7003–7009.
In addition to cancer-related death, malignant progression also causes a series of symptoms and side-effects that influence patients' quality of life detrimentally, influence their adherence to treatments adversely, and, thus, affect their long-term survival negatively. Needle acupuncture and electroacupuncture (EA).
This review summarized the clinical application of needle acupuncture and EA for alleviating cancer symptoms, reducing cancer treatment–related side-effects, and relieving cancer-related pain. The symptoms and side-effects discussed in this review included fatigue, insomnia, chemotherapy-associated dyspepsia syndrome, pain, xerostomia, anxiety, and depression. The authors suggested that the underlying mechanisms of the therapeutic effects of needle acupuncture and EA might be related to regulation of mitochondrial function, coordination of nervous system activity, adjustment of neurotransmitters' production, and alleviation of immune responses.
The reviewers concluded that needle acupuncture and EA have proven to be beneficial for patients who have cancer. However, more research is required to clarify the potential mechanisms behind needle acupuncture and EA for widespread use in clinical settings.
Jiang J, Liu H, Wang Z, Tian H, Wang S, Yang J, Ren J. PLoS One. 2021;16(11):e0259530.
A
EA improved the SAMP8 mice's learning and memory abilities (P < 0.05) and protected the frontal-lobe cortices and hippocampi of the SAMP8 mice. EA also significantly decreased expression of interleukin (IL)–1β (P < 0.01), IL-6 (P < 0.01), and tumor necrosis factor–α in hippocampi (P < 0.01) and in sera (P < 0.05). In addition, EA balanced the quantity and composition of the gut microbiome, especially the relative abundance of Δ-proteobacteria (P < 0.05) and E-proteobacteria (P < 0.05).
In conclusion, EA treatment could inhibit the peripheral and central nerve systems' inflammatory responses by balancing the gut microbiota.
Afrasiabi J, McCarty R, Hayakawa J, Barrows J, Lee K, Plouffe N, Schomberg J. J Trauma Nurs. 2021;28(6):350–362.
H
Interventions were delivered over 3 weeks. Self-reported State-Trait Anxiety Inventory (STAI), Professional Quality of Life (ProQoL), and Caring Ability Inventory (CAI) scores were analyzed using a pre/post-test design. Univariate analysis, Fisher's exact test, and an analysis of variance (ANOVA) were performed to assess group differences.
The results were stratified based on each subject's level of belief in Traditional Chinese Medicine. A total of 117 (36%) of 325 eligible participants consented to participate in the study. Seed acupressure treatment (n = 14, 35.9%, 1 male, 13 females) was associated with a reduction in burnout (ANOVA, P = 0.04) and secondary traumatic stress (P = 0.03). This effect remained significant after adjusting for individual pretest scores (ANOVA; P = 0.05). The interventions did not have significant effects on STAI, ProQoL, or CAI scores.
Auricular acupressure, according to the researchers, is a safe, effective, and practical strategy for reducing burnout and secondary traumatic stress and may support health care workers' ability to develop caring relationships with patients and families.
Liu ST, Zhan C, Ma YJ, Guo CY, Chen W, Fang XM, Fang L. Integr Med Res. 2021;10(suppl):100796.
T
QARP consisted of acupressure therapy and Qigong exercise (Liu Zi Jue). The primary outcome was measured with the modified Medical Research Council (mMRC) dyspnea scale, and the secondary outcomes included the modified Borg dyspnea scale, Fatigue Scale-14 (FS-14), Patient Health Questionnaire–9 scale, duration of respiratory symptoms, and vital signs.
In total, 128 patients completed the clinical trial. The QARP group + standard therapies and the standard therapies–alone group had significant improvements in vital signs (except blood pressure) and clinical scale scores compared with baseline (P < 0.05). The QARP + standard therapies group had more-significant improvements in mMRC dyspnea scale scores (−1.8 [–2.1, −1.6]; P = 0.018) and in modified Borg dyspnea scale scores (−3.7 [95% confidence interval (CI): −4.3, −3.1]; P = 0.045). Duration of cough was 14.3 days (95% CI: 12.6, 16.1; P = 0.046) and the length of hospital stay was 18.5 days (95% CI: 17.0, 20.0; P = 0.042) in the QARP + standard therapies group, both of which were significantly reduced, compared with the standard therapies–alone group (P < 0.05).
In patients with severe COVID-19, QARP + standard therapies improved lung function, reduced such symptoms as dyspnea and cough, and shortened the length of hospital stay. Therefore, QARP may be considered an effective additional treatment option for patients with severe COVID-19.
Huang H, Wang J, Li H, et al. BMJ Open. 2021;11(11):e049245.
P
The primary outcome sought will be visual-field mean sensitivity and visual-field mean deviation at 3, 6, and 9 months, compared with baseline. Secondary outcomes will include best-corrected visual acuity, central macular thickness, subfoveal choroidal thickness, Traditional Chinese Medicine syndrome score, and a scale of life quality for diseases with visual impairment at 3, 6, and 9 months, compared with baseline. Adverse events and safety indices will be recorded throughout the study. SPSS, version 25.0, statistical software will be used for analysis, and measurement data will be expressed as mean ± standard deviation.
Ethics approval has been obtained from the Ethics Committee of the Chinese Clinical Trial Registry (approval No: ChiECRCT20200460).
Huang S, Li L, Liu J, et al. Evid-Based Complement Alternat Med. 2021;2021:7228033.
A
The primary outcome was a change in the frequency of angina attacks from baseline. The secondary outcomes included nitroglycerin consumption, Canadian Cardiovascular Society classification, and Seattle Angina Questionnaire score. Adverse events, such as bleeding and subcutaneous hemorrhage, were recorded in both groups.
Acupressure, compared with baseline, for preventing angina pectoris episodes in the HSG was better than that in the LSG at week 4 (incidence rate ratio [IRR]: 0.691 and 95% confidence interval [CI]: 0.569, 0.839) and week 8 (IRR: 0.692 and 95% CI: 0.569, 0.839). No significant differences between the groups were found in frequency of nitroglycerin consumption at week 4 (odds ratio [OR] = 0.863 and 95% CI: 0.147, 5.077) or week 8 (OR = 1.426 and 95% CI: 0.211, 9.661).
Two themes in the questionnaire showed significantly different changes from baseline between the 2 groups. Scores on the angina frequency subscale had changed more from the baseline in the HSG at week 8 than in the LSG (mean difference [MD] = 3.807 and 95% CI: 0.673, 6.942). Scores on the treatment satisfaction subscale had also changed more in the HSG than in the LSG at week 4 (MD = 3.651 and 95% CI: 0.327, 7.327) and week 8 (MD = 4.220 and 95% CI: 0.347, 7.346). One patient in the LSG reported bruising at an acupoint. No unexpected safety problems arose.
This study showed that acupressure at acupoints with high sensitivity to pain may reduce the frequency of stable angina pectoris episodes effectively. This trial was registered as NCT03975140.
